Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | KCNQ2 | O43526 | 4/20 | 0.37 |
| ▸ | CSNK1D | P48730 | 3/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.35 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.35 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.35 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.34 |
| ▸ | PLCG2 | P16885 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6708770 | 0.94 | GRIK1 (0.41) | GRIK1MEN1KMT2AALDH1A1LMNA | |
| SCHEMBL6707655 | 0.93 | GRIK1 (0.45) | GRIK1MEN1KMT2AALDH1A1LMNA | |
| SCHEMBL6710051 | 0.92 | MEN1 (0.40) | GRIK1MEN1KMT2AALDH1A1GPR35 | |
| SCHEMBL6712138 | 0.92 | PARP14 (0.43) | GRIK1MEN1KMT2AALDH1A1LMNA | |
| SCHEMBL6707815 | 0.91 | PARP14 (0.42) | GRIK1MEN1KMT2APOLBKCNQ2 | |
| SCHEMBL6711931 | 0.91 | L3MBTL1 (0.38) | GRIK1MEN1KMT2APOLBKCNQ2 | |
| SCHEMBL6713651 | 0.90 | MEN1 (0.44) | GRIK1MEN1KMT2A | |
| SCHEMBL6713652 | 0.89 | GRIK1 (0.45) | GRIK1MEN1KMT2AALDH1A1LMNA | |
| SCHEMBL6918285 | 0.89 | PARP14 (0.42) | GRIK1MEN1KMT2AALDH1A1LMNA | |
| SCHEMBL6707749 | 0.89 | GRIK1 (0.42) | GRIK1MEN1KMT2ALMNAPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040142981-A1 | Antibacterial benzoic acid derivatives | PHARMACIA & UPJOHN COMPANY | 2004-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040142981-A1 | Antibacterial benzoic acid derivatives | GABRD, PHB1, GABBR1 | GRIK1 3885/4885MEN1 4100/4885KMT2A 3181/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.